Pilot Study of Hepatitis C Virus Entry Inhibitor (ITX 5061) in Liver Transplant Recipients
Status:
Completed
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
This is a phase I pilot study to determine the safety and preliminary efficacy of a novel
hepatitis C virus (HCV) entry inhibitor (ITX 5061) in patients with HCV infection undergoing
liver transplantation.
Phase:
Phase 1
Details
Lead Sponsor:
University of Birmingham
Collaborators:
National Institute for Health Research, United Kingdom University Hospital Birmingham